| Customization: | Available |
|---|---|
| CAS No.: | 104344-23- |
| Formula: | C22h35no |
|
Still deciding? Get samples of US$ 50/Piece
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Product name: Bisoprolo fumarate
CAS No: 104344-23-
Bisoprolo fumarate is a cardioselective beta-blocker that is commonly used to manage hypertension and heart failure. It works by blocking beta-1 adrenergic receptors in the heart, which results in a reduction of heart rate, blood pressure, and myocardial oxygen demand. This leads to improved cardiac function and reduced strain on the heart. Bisoprolo fumarate is typically administered as its fumarate salt form, which enhances the drug's stability and bioavailability.
Application and Effect
Bisoprolo fumarate is widely used in the management of hypertension (high blood pressure) and chronic heart failure. Its primary action is selective inhibition of the beta-1 adrenergic receptors located primarily in the heart. By blocking these receptors, bisoprolo decreases the heart rate (negative chronotropy) and contractility (negative inotropy), which in turn lowers blood pressure and reduces the workload on the heart. This makes it beneficial for patients with cardiovascular conditions such as hypertension, coronary artery disease, and heart failure. In heart failure, bisoprolo has been shown to improve left ventricular function and reduce the risk of hospitalization or death. It helps in stabilizing the heart's rhythm and reducing symptoms such as shortness of breath, fatigue, and swelling. Bisoprolo fumarate is often prescribed in combination with other heart failure medications, such as ACE inhibitors, diuretics, and angiotensin II receptor blockers (ARBs), for more comprehensive treatment. In addition to its heart-related effects, bisoprolo is also used for controlling the symptoms of angina (chest pain) and may be utilized after a heart attack to improve survival rates. Its cardioselectivity, meaning it specifically targets beta-1 receptors in the heart, reduces the risk of respiratory side effects seen with non-selective beta-blockers, making it suitable for patients with respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD). Bisoprolo fumarate is generally well-tolerated, with side effects typically including fatigue, dizziness, and bradycardia (slow heart rate).
Specifications:
| Composition | C22H35NO |
| Assay | 99% |
| Appearance | White solid |
| CAS No. | 104344-23- |
| Packing | Small and bulk |
| Shelf Life | 2 years |
| Storage | Store in cool and dry area |
| Certification | ISO. |
){kind=link}